Compare Packaging Corporation of America (PKG) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Packaging Corporation of America trades at $230.51 (market cap $20.49B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 2.9× Packaging Corporation of America's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| PKG | TAK | |
|---|---|---|
Market Cap | $20.49B | $58.74B |
Volume | 493,499 | 3,110,994 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $19.05 |
52-Week Low | $191.68 | $13.23 |
Typical Hold Time | 45 Days | 1 Days |
Enterprise Value | $24.30B | $86.65B |
Dividend Yield | 2.61% | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $229.94, up 1.18% on the day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, with Q2 2026 beating estimates but Q4 2025 missing, while revenue grew to $9.5 billion in 2026. Analyst consensus is a Buy with a $272.43 price target, though net cash flow turned negative in 2026.
PKG offers a stable dividend and benefits from consistent packaging demand, but faces margin pressure from rising costs. The stock's valuation appears elevated with a P/E of 29.86, and negative cash flow trends pose a risk. Upside depends on cost management and execution of growth initiatives amid economic uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
